Journal of Microbiology

The Microbiological Society of Korea (한국미생물학회)
권호 표지

Improved Inhibition of Human Immunodeficiency Virus Type 1 Replication by Intracellular Co-overexpression of TAR and RRE Decoys in Tandem Array

  • Lee, Seong-Wook (Department of Molecular Biology & Institute of Nanosensor and Biotechnology, Dankook University)
  • Published : 2003.01.01
Download PDF
⟨ Previous Next ⟩

Abstract

Intracellular expression of RNA decoys, such as TAR or RRE decoy, has been previously shown to protect immune cells from human immunodeficiency virus type 1 (HIV-1) replication by inhibiting the binding of the HIV-1 regulatory protein to the authentic HIV RNA sequence. However, HIV-1 challenge experiments of primary human T cells, which express the RNA decoy, demonstrated that the cells were only transiently protected, and hence, more improved protocols for HIV-1 inhibition with the RNA decoys need to be developed. In this report, in order to develop a more effective RNA decoy, we analyzed and compared the ability of a series of RNA decoy derivatives in inhibiting HIV-1 replication in CEM cells. Using an improved tRNA cassette to express high levels of RNA decoy transcripts in cells, we found that co-expression of both TAR and RRE decoys, in the form of an aligned sequence in a single transcription cassette, much more potently blocked cells from HIV-1 than the expression of only one kind of RNA decoy. This observation will have an important implication for experiments involving optimization of clinical applications in RNA decoy-based gene therapy against HIV-1.

Keywords

References

  1. Bae, S.-J., J.-H. Oum, S. Sharma, J. Park, and S.-W. Lee. 2002. In vitro selection of specific RNA inhibitors of NFATc. Biochem. Biophys. Res. Commun. 298, 486-492. https://doi.org/10.1016/S0006-291X(02)02490-7
  2. Cheong, C., G. Varani, and J. Tinoco. 1990. Solution structure of an unusually stable RNA hairpin. 5'GGAC(UUCG)GUCC. Nature 346, 680-682.
  3. Cho, H.-I., S.-Y. Paik, I.-H. Oh, K.-J. Ahn, D.-W. Kim, J.-H. Kang, W.-S. Shin, C.-C. Kim, H. Han, and T.-G. Kim. 2001. Efficient generation of BLCL expressing foreign antigen as antigen-presenting cells with recombinant retroviruses. J. Microbiol. 39, 300-304.
  4. Emerman, M. and M.H. Malim. 1998. HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology. Science 280, 1880-1884.
  5. Gilboa, E. and C. Smith. 1994. Gene therapy for infectious diseases: the AIDS model. Trends Genet. 10, 139-144.
  6. Hantzopoulos, P., B. Sullenger, G. Ungers, and E. Gilboa. 1989. Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retro-viral vector. Proc. Natl. Acad. Sci. USA 86, 3519-3523.
  7. Heaphy, S., J. Finch, M. Gait, J. Karn, and M. Singh. 1991. Human immunodeficiency virus type I regulator of virion expression, rev, forms, nucleoprotein filaments after binding to a purinerich 'ubble'located within the rev-responsive region of viral mRNAs. Proc. Natl. Acad. Sci. USA 88, 7366-7370.
  8. Jaeger, J., D. Turner, and M. Zuker. 1989. Improved predictions of secondary structures for RNA. Proc. Natl. Acad. Sci. USA 86, 7706-7710.
  9. Lee, S.-W., H.F. Gallardo, E. Gilboa, and C. Smith. 1994. Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain. J. Virol. 68, 8254-8264.
  10. Lee, S.-W., H.F. Gallardo, O. Gasper, C. Smith, and E. Gilboa. 1995. Inhibition of HIV-1 in CEM cells by a potent TAR decoy. Gene Ther. 2, 377-384.
  11. Lee, S.-W. 1998. Studies on the inhibition of HIV replication with a number of RRE decoy derivatives. J. Microbiol. 36, 308-315.
  12. Markowitz, D., S. Goff, and A. Bank. 1988. Construction and use of a safe and efficient amphotropic packaging cell line. Virology 167, 400-406.
  13. Martinez-Picado, J., M.P. DePasquale, N. Kartsonis, G.J. Hanna, J. Wong, D. Finzi, E. Rosenberg, H.F. Gunthard, L. Sutton, A. Savara, C.J. Petropoulos, N. Hellmann, B.D. Walker, D.D. Richman, R. Siliciano, and R.T. D'Aquila. 2000. Antiretroviral resistance during successful therapy of HIV type 1 infection. Proc. Natl. Acad. Sci. USA 97, 10948-10953.
  14. Nara, P. and P. Fischinger. 1988. Quantitative infectivity assay for HIV-1 and -2. Nature 332, 469-470.
  15. Rosen, C. and G. Pavlakis. 1990. Tat and Rev: positive regulators of HIV gene expression. AIDS 4, 499-509.
  16. Sanchez-Pescador, R., M. Power, P. Barr, K. Steimer, M. Stempien, S. Brown-Shimer, W. Gee, A. Renard, A. Randolph, J. Levy, D. Dina, and P. Luciw. 1985. Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). Science 227, 484-492.
  17. Smith, C., S.-W. Lee, E. Wong, H. Gallardo, K. Page, O. Gasper, J. Lebkowski, and E. Gilboa. 1996. Transient protection of human T-cells from human immunodeficiency virus type 1 infection by transduction with adeno-associated viral vectors which express RNA decoys. Antiviral Res. 32, 99-115.
  18. Statham, S. and R.A. Morgan. 1999. Gene therapy clinical trials for HIV. Curr. Opin. Mol. Ther. 1, 430-436.
  19. Sullenger, B., H. Gallardo, G. Ungers, and E. Gilboa. 1990. Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell 63, 601-608.
  20. Sullenger, B., H. Gallardo, G. Ungers, and E. Gilboa. 1991. Analysis of trans-acting response decoy RNA mediated inhibition of human immunodeficiency virus type 1 transactivation. J. Virol. 65, 6811-6816.
  21. Sullenger, B.A. and E. Gilboa. 2002. Emerging clinical applications of RNA. Nature 418, 252-258.
  22. Tuerk, C., P. Gauss, C. Thermes, D. Groebe, M. Gayle, N. Guild, G. Stormo, Y. Aubenton-Carafa, O. Uhlenbeck, J. Tinoco, I. Brody, and L. Gold. 1988. CUUCGG hairpins: extraordinarily stable RNA secondary structures associated with various biochemical processes. Proc. Natl. Acad. Sci. USA 85, 1364-1368.
  23. Tuerk, C. and L. Gold. 1990. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505-510.